- Home
- WBA vs BBIO Comparison
WBA vs BBIO Comparison
Compare WBA & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBA
- BBIO
- Stock Information
- Founded
- WBA 1901
- BBIO 2015
- Country
- WBA United States
- BBIO United States
- Employees
- WBA N/A
- BBIO N/A
- Industry
- WBA Retail-Drug Stores and Proprietary Stores
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- WBA Consumer Staples
- BBIO Health Care
- Exchange
- WBA Nasdaq
- BBIO Nasdaq
- Market Cap
- WBA 10.0B
- BBIO 8.8B
- IPO Year
- WBA N/A
- BBIO 2019
- Fundamental
- Price
- WBA $11.96
- BBIO $51.32
- Analyst Decision
- WBA Hold
- BBIO Strong Buy
- Analyst Count
- WBA 11
- BBIO 16
- Target Price
- WBA $10.59
- BBIO $61.69
- AVG Volume (30 Days)
- WBA 7.0M
- BBIO 2.9M
- Earning Date
- WBA 10-14-2025
- BBIO 08-05-2025
- Dividend Yield
- WBA N/A
- BBIO N/A
- EPS Growth
- WBA N/A
- BBIO N/A
- EPS
- WBA N/A
- BBIO N/A
- Revenue
- WBA $154,581,000,000.00
- BBIO $235,812,000.00
- Revenue This Year
- WBA $5.52
- BBIO $106.33
- Revenue Next Year
- WBA $1.56
- BBIO $54.30
- P/E Ratio
- WBA N/A
- BBIO N/A
- Revenue Growth
- WBA 6.22
- BBIO 7.62
- 52 Week Low
- WBA $8.08
- BBIO $21.72
- 52 Week High
- WBA $13.25
- BBIO $51.86
- Technical
- Relative Strength Index (RSI)
- WBA 70.86
- BBIO 68.33
- Support Level
- WBA $11.84
- BBIO $42.09
- Resistance Level
- WBA $11.97
- BBIO $51.86
- Average True Range (ATR)
- WBA 0.08
- BBIO 1.90
- MACD
- WBA 0.02
- BBIO 0.30
- Stochastic Oscillator
- WBA 72.55
- BBIO 94.47
About WBA Walgreens Boots Alliance Inc.
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.